Ferritin-Based Mild Magnetic Hyperthermia Therapy for Bladder Cancer: A Synergistic Anti-Inflammatory Strategy
Source abstract
Abstract
Bladder cancer treatment is challenged by tissue damage, inflammation, and resistance to mild hyperthermia. Magnetic hyperthermia therapy offers a promising solution, but issues such as rapid nanoparticle clearance and limited tumor retention still hinder its effectiveness. Here, we report a mild magnetic hyperthermia strategy that integrates pH-responsive magnetic ferritin with a glutathione-activated nitric oxide donor to sensitize tumors while minimizing off-target damage. Under an alternating magnetic field, ferritin-confined Fe 3 O 4 cores generate subablative heat through relaxation losses, while the ferritin shell ensures biocompatibility, enhances tumor uptake, and captures cyanoferrate byproducts to mitigate side effects. Combined with nitric oxide gas therapy, this regimen weakens tumor thermotolerance, reverses the immunosuppressive tumor microenvironment, induces an abscopal effect, and dampens NF-κB-mediated inflammatory signaling. By integrating tumor targeting, alleviation of immunosuppression, and inflammation control, this approach achieves greater tumor regression and better systemic tolerability than monotherapy, thereby advancing hyperthermia therapy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Bladder and Urothelial Cancer Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Biogeomagnetism Lab, Key Laboratory of Planetary Science and Frontier Technology
Institute of Geology and Geophysics, Chinese Academy of Sciences
College of Earth and Planetary Sciences
University of the Chinese Academy of Sciences
Key Laboratory of Deep Petroleum Intelligent Exploration and Development, Center for Oil-Gas Theories and Methods
Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College
Huazhong University of Science and Technology
Funding
National Natural Science Foundation of China
References (57)
Show source-provided references
1. 10.1038/s41572-023-00468-910.1038/s41572-023-00468-9 ↗
2. 10.1136/bmj-2023-07674310.1136/bmj-2023-076743 ↗
3. 10.1016/j.eururo.2025.02.01010.1016/j.eururo.2025.02.010 ↗
4. 10.1021/acsnano.3c0417510.1021/acsnano.3c04175 ↗
5. 10.1016/j.cej.2022.13784610.1016/j.cej.2022.137846 ↗
6. 10.1021/jacs.2c0960810.1021/jacs.2c09608 ↗
7. 10.1021/acsnano.1c0560510.1021/acsnano.1c05605 ↗
8. 10.1002/adfm.20240207810.1002/adfm.202402078 ↗
9. 10.1021/acsnano.4c1873210.1021/acsnano.4c18732 ↗
10. 10.1002/anie.20250591110.1002/anie.202505911 ↗
11. 10.1016/j.biomaterials.2024.12251410.1016/j.biomaterials.2024.122514 ↗
12. 10.1016/j.bioactmat.2025.07.03310.1016/j.bioactmat.2025.07.033 ↗
13. 10.1016/j.mtbio.2025.10207010.1016/j.mtbio.2025.102070 ↗
14. 10.1002/adfm.20241841110.1002/adfm.202418411 ↗
15. 10.1039/D5MH00317B10.1039/D5MH00317B ↗
16. 10.1002/smm2.127610.1002/smm2.1276 ↗
17. 10.1016/j.ccr.2025.21657510.1016/j.ccr.2025.216575 ↗
18. 10.34133/2020/897013510.34133/2020/8970135 ↗
19. 10.1002/smll.20240635110.1002/smll.202406351 ↗
20. 10.1002/smll.20241045410.1002/smll.202410454 ↗
21. 10.7150/thno.8082110.7150/thno.80821 ↗
22. 10.1002/adfm.20200204310.1002/adfm.202002043 ↗
23. 10.1002/smll.20170104510.1002/smll.201701045 ↗
24. 10.1002/adma.20130454410.1002/adma.201304544 ↗
25. 10.1002/adma.20250523110.1002/adma.202505231 ↗
26. 10.1038/s44222-024-00257-310.1038/s44222-024-00257-3 ↗
27. 10.1016/j.cej.2025.16027110.1016/j.cej.2025.160271 ↗
28. 10.1016/j.jconrel.2023.01.00110.1016/j.jconrel.2023.01.001 ↗
29. 10.1002/smll.20230484810.1002/smll.202304848 ↗
30. 10.1021/acsnano.4c0388710.1021/acsnano.4c03887 ↗
31. 10.1002/anie.20210703610.1002/anie.202107036 ↗
32. 10.1039/D5CC00219B10.1039/D5CC00219B ↗
33. 10.1002/EXP.2023016310.1002/EXP.20230163 ↗
34. 10.1002/smll.20231070610.1002/smll.202310706 ↗
35. 10.1021/acsnano.5c0849910.1021/acsnano.5c08499 ↗
36. 10.1021/acsnano.7b0021610.1021/acsnano.7b00216 ↗
37. 10.1039/D1CS00427A10.1039/D1CS00427A ↗
38. 10.3390/nano910145710.3390/nano9101457 ↗
39. 10.1016/j.canlet.2024.21714510.1016/j.canlet.2024.217145 ↗
40. 10.1016/j.ccr.2023.21505210.1016/j.ccr.2023.215052 ↗
41. 10.1038/s41467-024-55665-110.1038/s41467-024-55665-1 ↗
42. 10.1038/s41585-023-00814-210.1038/s41585-023-00814-2 ↗
43. 10.1038/s41467-021-25501-x10.1038/s41467-021-25501-x ↗
44. 10.1021/acsnano.5c0837910.1021/acsnano.5c08379 ↗
45. 10.1038/s43018-022-00468-w10.1038/s43018-022-00468-w ↗
46. 10.1016/j.scib.2023.11.02710.1016/j.scib.2023.11.027 ↗
47. 10.1038/s41568-020-0281-y10.1038/s41568-020-0281-y ↗
48. 10.1038/s41573-025-01210-810.1038/s41573-025-01210-8 ↗
49. 10.1016/j.immuni.2022.12.00310.1016/j.immuni.2022.12.003 ↗
50. 10.1016/j.nantod.2022.10165610.1016/j.nantod.2022.101656 ↗
51. 10.1021/acsnano.4c1744410.1021/acsnano.4c17444 ↗
52. 10.1016/j.mattod.2023.05.02410.1016/j.mattod.2023.05.024 ↗
53. 10.1038/s41587-025-02597-w10.1038/s41587-025-02597-w ↗
54. 10.1038/s41586-025-09518-610.1038/s41586-025-09518-6 ↗
55. 10.1038/s41467-023-38796-910.1038/s41467-023-38796-9 ↗
56. 10.1093/nar/gkab108110.1093/nar/gkab1081 ↗
57. 10.1093/nar/gky86910.1093/nar/gky869 ↗